Bioelectronics Corp (BIEL)

[kidnova]

That's standard in most struggling OTC traded companies, although they usually include language such as "Management believes they will be able to obtain sufficient financing to continue operations though for the next XX months."

One thing I do find interesting is that they noted sales to eMarket of $980 for the quarter, and nine month sales of $214,767. That doesn't seem odd on the surface, but in their Q2 filing they noted 6 month sales of $236,301. So sales YTD sales actually dropped $21,534 in Q3.